Biglycan mRNA in LM-TECs was upregulated after treatment with HM-tumour-CM (Supplementary Fig. S3B) and the number of migrating LM-tumour cells increased when HM-tumour CM-treated LM-TECs were plated in the lower chambers of transwells (Supplementary Fig. S3C). The gene discussed is BGN; the disease is neoplasm.